Mechanistic analysis of the antitumor efficacy of human natural killer cells against breast cancer cells

Breast Cancer Research and Treatment

Volumn 134, Issue 1, 2012, Pages 139-155

  Kajitani, Keiko ^a   Tanaka, Yuka ^a   Arihiro, Koji ^b   Kataoka, Tsuyoshi ^b   Ohdan, Hideki ^a  

^a HIROSHIMA UNIVERSITY   (Japan)

^b HIROSHIMA UNIVERSITY   (Japan)

Author keywords

ADCC; Breast cancer; Chemokine; NK cells; TNF related apoptosis inducing ligand (TRAIL); TRAIL receptors

Indexed keywords

CHEMOKINE RECEPTOR CXCR3; CONCANAMYCIN A; CXCL11 CHEMOKINE; CXCL9 CHEMOKINE; DCR1 RECEPTOR; DCR2 RECEPTOR; DEATH RECEPTOR 4; EPIDERMAL GROWTH FACTOR RECEPTOR 2; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 2; MONOCLONAL ANTIBODY; PERFORIN; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND ANTIBODY; UNCLASSIFIED DRUG;

ANALYSIS; ANTINEOPLASTIC ACTIVITY; ARTICLE; BLOOD; BREAST CANCER; CANCER CELL; CELL MIGRATION; CELL STRAIN; CONTROLLED STUDY; CYTOKINE RELEASE; HUMAN; HUMAN CELL; LIVER; LIVER CELL; MECHANISTIC ANALYSIS; MONONUCLEAR CELL; NATURAL KILLER CELL; NATURAL KILLER CELL MEDIATED CYTOTOXICITY; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; UPREGULATION;

ANTIBODIES, MONOCLONAL, HUMANIZED; ANTIBODY-DEPENDENT CELL CYTOTOXICITY; ANTIGENS, CD; ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CELL MOVEMENT; CELLS, CULTURED; CHEMOKINE CXCL10; COCULTURE TECHNIQUES; FEMALE; HUMANS; IMMUNOTHERAPY; INTERLEUKIN-2; KILLER CELLS, NATURAL; LEUKOCYTES, MONONUCLEAR; LIVER; PERFORIN; PHENOTYPE; RECEPTORS, CXCR3; RECEPTORS, DEATH DOMAIN; TNF-RELATED APOPTOSIS-INDUCING LIGAND;

EID: 84863983149     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-011-1944-x     Document Type: Article

References (50)

1. G Trinchieri 1989 Biology of natural killer cells Adv Immunol 47 187 376 2683611 10.1016/S0065-2776(08)60664-1 1:STN:280:DyaK3c%2Flt1yrsw%3D%3D
2. MJ Robertson J Ritz 1990 Biology and clinical relevance of human natural killer cells Blood 76 12 2421 2438 2265240 1:STN:280:DyaK3M%2FptFCkug%3D%3D
3. SP Cullen SJ Martin 2008 Mechanisms of granule-dependent killing Cell Death Differ 15 2 251 262 17975553 10.1038/sj.cdd.4402244 1:CAS:528: DC%2BD1cXmsVOrsQ%3D%3D
4. J Pardo JI Aguilo A Anel P Martin L Joeckel C Borner, et al. 2009 The biology of cytotoxic cell granule exocytosis pathway: granzymes have evolved to induce cell death and inflammation Microbes Infect 11 4 452 459 19249384 10.1016/j.micinf.2009.02.004 1:CAS:528:DC%2BD1MXkslyku7s%3D
5. J Sjostrom-Mattson K Von Boguslawski NO Bengtsson I Mjaaland K Salmenkivi C Blomqvist 2009 The expression of p53, bcl-2, bax, fas and fasL in the primary tumour and lymph node metastases of breast cancer Acta Oncol 48 8 1137 1143 19863221 10.3109/02841860902988688 1:CAS:528:DC%2BD1MXhsFOqurrF
6. L Lahiry B Saha J Chakraborty A Adhikary DM Hossain, et al. 2010 Theaflavins target Fas/caspase-8 and Akt/pBad pathways to induce apoptosis in p53-mutated human breast cancer cells Carcinogenesis 31 2 259 268 19969555 10.1093/carcin/bgp240 1:CAS:528:DC%2BC3cXhsVWju7c%3D
7. M Takahashi K Ogasawara K Takeda W Hashimoto H Sakihara K Kumagai, et al. 1996 LPS induces NK1.1+ alpha beta T cells with potent cytotoxicity in the liver of mice via production of IL-12 from Kupffer cells J Immunol 156 7 2436 2442 8786302 1:CAS:528:DyaK28XhvVGltrs%3D
8. IN Crispe WZ Mehal 1996 Strange brew: T cells in the liver Immunol Today 17 11 522 525 8961629 10.1016/S0167-5699(96)80906-6 1:CAS:528:DyaK28XntVKrsro%3D
9. S Seki Y Habu T Kawamura K Takeda H Dobashi T Ohkawa, et al. 2000 The liver as a crucial organ in the first line of host defense: the roles of Kupffer cells, natural killer (NK) cells and NK1.1 Ag+ T cells in T helper 1 immune responses Immunol Rev 174 35 46 10807505 10.1034/j.1600-0528.2002.017404.x 1:CAS:528:DC%2BD3cXjtVygsr4%3D
10. K Ishiyama H Ohdan H Mitsuta K Arihiro T Asahara 2006 Difference in cytotoxicity against hepatocellular carcinoma between liver and periphery natural killer cells in humans Hepatology 43 2 362 372 16440347 10.1002/hep.21035 1:CAS:528:DC%2BD28XhvVSnsLs%3D
11. M Ochi H Ohdan H Mitsuta T Onoe D Tokita H Hara, et al. 2004 Liver NK cells expressing TRAIL are toxic against self hepatocytes in mice Hepatology 39 5 1321 1331 15122761 10.1002/hep.20204 1:CAS:528:DC%2BD2cXks1Sjtbw%3D
12. M Rahman SR Davis JG Pumphrey J Bao MM Nau PS Meltzer, et al. 2009 TRAIL induces apoptosis in triple-negative breast cancer cells with a mesenchymal phenotype Breast Cancer Res Treat 113 2 217 230 18266105 10.1007/s10549-008- 9924-5
13. K Dastjerdi GH Tabar H Dehghani A Haghparast 2011 Generation of an enriched pool of DNA aptamers for an HER2-overexpressing cell line selected by cell SELEX Biotechnol Appl Biochem 58 4 226 230 21838796 10.1002/bab.36 1:CAS:528:DC%2BC3MXhtVOlu7%2FI
14. T Kataoka N Shinohara H Takayama K Takaku S Kondo S Yonehara, et al. 1996 Concanamycin A, a powerful tool for characterization and estimation of contribution of perforin- and Fas-based lytic pathways in cell-mediated cytotoxicity J Immunol 156 10 3678 3686 8621902 1:CAS:528:DyaK28XivVanu7k%3D
15. N Kawarabayashi S Seki K Hatsuse T Ohkawa Y Koike T Aihara, et al. 2000 Decrease of CD56(+)T cells and natural killer cells in cirrhotic livers with hepatitis C may be involved in their susceptibility to hepatocellular carcinoma Hepatology 32 5 962 969 11050046 10.1053/jhep.2000.19362 1:STN:280: DC%2BD3M%2FivFalsQ%3D%3D
16. G Pan K O'Rourke AM Chinnaiyan R Gentz R Ebner J Ni, et al. 1997 The receptor for the cytotoxic ligand TRAIL Science 276 5309 111 113 9082980 10.1126/science.276.5309.111 1:CAS:528:DyaK2sXitl2jsL4%3D
17. JP Sheridan SA Marsters RM Pitti A Gurney M Skubatch D Baldwin, et al. 1997 Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors Science 277 5327 818 821 9242611 10.1126/science.277.5327.818 1:CAS:528:DyaK2sXlt1eks78%3D
18. RP Wallin V Screpanti J Michaelsson A Grandien HG Ljunggren 2003 Regulation of perforin-independent NK cell-mediated cytotoxicity Eur J Immunol 33 10 2727 2735 14515256 10.1002/eji.200324070 1:CAS:528:DC%2BD3sXosFSjsbo%3D
19. TP Salazar-Mather JS Orange CA Biron 1998 Early murine cytomegalovirus (MCMV) infection induces liver natural killer (NK) cell inflammation and protection through macrophage inflammatory protein 1alpha (MIP-1alpha)-dependent pathways J Exp Med 187 1 1 14 9419206 10.1084/jem.187.1.1 1:CAS:528: DyaK1cXjtV2nsg%3D%3D
20. MJ Guimond B Wang BA Croy 1998 Engraftment of bone marrow from severe combined immunodeficient (SCID) mice reverses the reproductive deficits in natural killer cell-deficient tg epsilon 26 mice J Exp Med 187 2 217 223 9432979 10.1084/jem.187.2.217 1:CAS:528:DyaK1cXkvVOnsA%3D%3D
21. JA Hedrick V Saylor D Figueroa L Mizoue Y Xu S Menon, et al. 1997 Lymphotactin is produced by NK cells and attracts both NK cells and T cells in vivo J Immunol 158 4 1533 1540 9029087 1:STN:280:DyaK2s7otVyluw%3D%3D
22. JR Groom AD Luster 2011 CXCR3 ligands: redundant, collaborative and antagonistic functions Immunol Cell Biol 89 2 207 215 21221121 10.1038/icb.2010.158 1:CAS:528:DC%2BC3MXitVCls7s%3D
23. MA Caligiuri A Zmuidzinas TJ Manley H Levine KA Smith J Ritz 1990 Functional consequences of interleukin 2 receptor expression on resting human lymphocytes. Identification of a novel natural killer cell subset with high affinity receptors J Exp Med 171 5 1509 1526 1692080 10.1084/jem.171.5.1509 1:CAS:528:DyaK3cXktlyls7Y%3D
24. A Nagler LL Lanier JH Phillips 1990 Constitutive expression of high affinity interleukin 2 receptors on human CD16-natural killer cells in vivo J Exp Med 171 5 1527 1533 2139697 10.1084/jem.171.5.1527 1:CAS:528: DyaK3cXktlyls7c%3D
25. MA Caligiuri C Murray MJ Robertson E Wang K Cochran C Cameron, et al. 1993 Selective modulation of human natural killer cells in vivo after prolonged infusion of low dose recombinant interleukin 2 J Clin Invest 91 1 123 132 7678599 10.1172/JCI116161 1:CAS:528:DyaK3sXhtVSisb8%3D
26. DM Baume MJ Robertson H Levine TJ Manley PW Schow J Ritz 1992 Differential responses to interleukin 2 define functionally distinct subsets of human natural killer cells Eur J Immunol 22 1 1 6 1370410 10.1002/eji.1830220102 1:CAS:528:DyaK38XhtVCju7Y%3D
27. K Karre HG Ljunggren G Piontek R Kiessling 1986 Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defence strategy Nature 319 6055 675 678 3951539 10.1038/319675a0 1:STN:280:DyaL287ks1yguw%3D%3D
28. SR Wiley K Schooley PJ Smolak WS Din CP Huang JK Nicholl, et al. 1995 Identification and characterization of a new member of the TNF family that induces apoptosis Immunity 3 6 673 682 8777713 10.1016/1074-7613(95)90057-8 1:CAS:528:DyaK28XhtF2iug%3D%3D
29. J Ogasawara R Watanabe-Fukunaga M Adachi A Matsuzawa T Kasugai Y Kitamura, et al. 1993 Lethal effect of the anti-Fas antibody in mice Nature 364 6440 806 809 7689176 10.1038/364806a0 1:CAS:528:DyaK3sXmt1elurg%3D
30. S Nagata 1997 Apoptosis by death factor Cell 88 3 355 365 9039262 10.1016/S0092-8674(00)81874-7 1:CAS:528:DyaK2sXhtFahtbg%3D
31. A Ashkenazi RC Pai S Fong S Leung DA Lawrence SA Marsters, et al. 1999 Safety and antitumor activity of recombinant soluble Apo2 ligand J Clin Invest 104 2 155 162 10411544 10.1172/JCI6926 1:CAS:528:DyaK1MXkslSmsbw%3D
32. H Walczak RE Miller K Ariail B Gliniak T Griffith M Kubin, et al. 1999 Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo Nat Med 5 2 157 163 9930862 10.1038/5517 1:CAS:528:DyaK1MXntlSrug%3D%3D
33. I Herr KM Debatin 2001 Cellular stress response and apoptosis in cancer therapy Blood 98 9 2603 2614 11675328 10.1182/blood.V98.9.2603 1:CAS:528:DC%2BD3MXotVegs7o%3D
34. A Nagler LL Lanier S Cwirla JH Phillips 1989 Comparative studies of human FcRIII-positive and negative natural killer cells J Immunol 143 10 3183 3191 2530273 1:CAS:528:DyaK3cXlvVSj
35. S Ishigami S Natsugome K Tokuda A Nakajo Che Xiangming H Iwashige, et al. 2000 Prognostic value of intratumoral natural killer cells in gastric carcinoma Cancer 88 3 577 583 10649250 10.1002/(SICI)1097-0142(20000201)88:3<577::AID- CNCR13>3.0.CO;2-V 1:STN:280:DC%2BD3c7hsFelsw%3D%3D
36. FR Villegas C Santiago VG Villarrubia R Jimenez MJ Chillon J Jareno, et al. 2002 Prognostic significance of tumor infiltrating natural killer cells subset CD57 in patients with squamous cell lung cancer Lung Cancer 35 1 23 28 11750709 10.1016/S0169-5002(01)00292-6
37. M Hyakudomi T Matsubara R Hyakudomi T Yamamoto S Kinugasa A Yamanoi, et al. 2008 Increased expression of fractalkine is correlated with a better prognosis and an increased number of both CD8+ T cells and natural killer cells in gastric adenocarcinoma Ann Surg Oncol 15 6 1775 1782 18363071 10.1245/s10434-008-9876-3
38. JS Miller Y Soignier A Panoskaltsis-Mortari SA McNearney GH Yun SK Fautsch, et al. 2005 Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancer Blood 105 8 3051 3057 15632206 10.1182/blood-2004-07-2974 1:CAS:528:DC%2BD2MXjtlSmtb0%3D
39. HG Klingemann J Martinson 2004 Ex vivo expansion of natural killer cells for clinical applications Cytotherapy 6 1 15 22 14985163 10.1080/ 14653240310004548
40. SA Rosenberg MT Lotze LM Muul AE Chang FP Avis S Leitman, et al. 1987 A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high-dose interleukin-2 alone N Engl J Med 316 15 889 897 3493432 10.1056/NEJM198704093161501 1:STN:280:DyaL2s7ksVGitA%3D%3D
41. MJ Brunda L Luistro RR Warrier RB Wright BR Hubbard M Murphy, et al. 1993 Antitumor and antimetastatic activity of interleukin 12 against murine tumors J Exp Med 178 4 1223 1230 8104230 10.1084/jem.178.4.1223 1:CAS:528: DyaK3sXlsFyjsL4%3D
42. K Takeda Y Hayakawa ML Smyth N Kayagaki N Yamaguchi S Kakuta, et al. 2001 Involvement of tumor necrosis factor-related apoptosis-inducing ligand in surveillance of tumor metastasis by liver natural killer cells Nat Med 1 94 100 10.1038/83416
43. MK Kennedy M Glaccum SN Brown EA Butz JL Viney M Embers, et al. 2000 Reversible defects in natural killer and memory CD8 T cell lineages in interleukin 15-deficient mice J Exp Med 191 5 771 780 10704459 10.1084/jem.191.5.771 1:CAS:528:DC%2BD3cXhslygtrc%3D
44. MJ Smyth E Cretney K Takeda RH Wiltrout LM Sedger N Kayagaki, et al. 2001 Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) contributes to interferon gamma-dependent natural killer cell protection from tumor metastasis J Exp Med 193 6 661 670 11257133 10.1084/jem.193.6.661 1:CAS:528: DC%2BD3MXitFKhs7Y%3D
45. JE Talmadge H Phillips J Schindler H Tribble R Pennigton 1987 Systematic preclinical study on the therapeutic properties of recombinant human interleukin 2 for the treatment of metastatic disease Cancer Res 47 21 5725 5732 3499218 1:CAS:528:DyaL2sXmtlCmtrs%3D
46. MW Helms JA Prescher YA Cao S Schaffert CH Contag 2010 IL-12 enhances efficacy and shortens enrichment time in cytokine-induced killer cell immunotherapy Cancer Immunol Immunother 59 9 1325 1334 20532883 10.1007/s00262-010-0860-y 1:CAS:528:DC%2BC3cXotVOlu78%3D
47. HJ Pegram NM Haynes MJ Smyth MH Kershaw PK Darcy 2010 Characterizing the anti-tumor function of adoptively transferred NK cells in vivo Cancer Immunol Immunother 59 8 1235 1246 20376439 10.1007/s00262-010-0848-7
48. EG Iliopoulou P Kountourakis MV Karamouzis D Doufexis A Ardavanis CN Baxevanis, et al. 2010 A phase I trial of adoptive transfer of allogeneic natural killer cells in patients with advanced non-small cell lung cancer Cancer Immunol Immunother 59 12 1781 1789 20703455 10.1007/s00262-010-0904-3
49. V Milani S Stangl R Issels M Gehrmann B Wagner K Hube 2009 Anti-tumor activity of patient-derived NK cells after cell-based immunotherapy-a case report J Transl Med 7 50 19549307 10.1186/1479-5876-7-50
50. DA Knorr DS Kaufman 2010 Pluripotent stem cell-derived natural killer cells for cancer therapy Transl Res 156 3 147 154 20801411 10.1016/j.trsl.2010. 07.008 1:CAS:528:DC%2BC3cXhtVylsL7J